Assembly Biosciences (ASMB) Capital Expenditures (QoQ) (2011 - 2026)
Assembly Biosciences (ASMB) Capital Expenditures (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Assembly Biosciences | 282.74 Mn | 56.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.83% |
| Dec 31, 2025 | -42.86% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 101.84% |
| Dec 31, 2023 | -202.70% |
| Sep 30, 2023 | 233.03% |
| Dec 31, 2022 | -638.82% |
| Sep 30, 2022 | 131.48% |
| Jun 30, 2022 | -214.41% |
| Mar 31, 2022 | 2,522.22% |
| Dec 31, 2021 | -99.47% |
| Sep 30, 2021 | 5,623.73% |
| Jun 30, 2021 | 116.48% |
| Sep 30, 2020 | -177.36% |
| Jun 30, 2020 | 9,569.57% |
| Mar 31, 2020 | -253.33% |
| Dec 31, 2019 | -99.53% |
| Sep 30, 2019 | 9,881.25% |
| Jun 30, 2019 | 101.90% |
| Mar 31, 2019 | -899.53% |